Tex. Occ. Code § 562.013 · Subchapter A. PRESCRIPTION AND SUBSTITUTION REQUIREMENTS
APPLICABILITY OF SUBCHAPTER.
Text — Current through the 89th 2nd Called Legislative Session, 2025
Unless a drug is determined to be generically equivalent to, or a biological product is determined to be interchangeable with, the brand prescribed, drug or biological product selection as authorized by this subchapter does not apply to:
(1) an enteric-coated tablet;
(2) a controlled release product;
(3) an injectable suspension, other than an antibiotic;
(4) a suppository containing active ingredients for which systemic absorption is necessary for therapeutic activity; or
(5) a different delivery system for aerosol or nebulizer drugs.
Notes and commentary — not statutory text
History
Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999.
Amended by:
Acts 2015, 84th Leg., R.S., Ch. 1007 (H.B. 751), Sec. 12, eff. September 1, 2015.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/OC/htm/OC.562.htm
- Text hash
- sha256 86000fd7c5070dadc12e56fd43ddf67320d0f94b825bed0ce9fb373e1fae41ab
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.